Wilbanks Smith & Thomas Asset Management LLC Neogenomics Inc Transaction History

Wilbanks Smith & Thomas Asset Management LLC

$3.54 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2018 Feb 08, 2019	SELL	$11.24 - $18.5 $3,518 - $5,790	-313 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $3,912 - $4,813	313 New	313 $5,000

Others Institutions Holding NEO

# of Institutions

276

Shares Held

127M

Call Options Held

581K

Put Options Held

115K

Black Rock Inc. New York, NY

19.7M
Shares

$311 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14.1M
Shares

$223 Million
0.0% of portfolio
Brown Advisory Inc

8.77M
Shares

$139 Million
0.16% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

6.73M
Shares

$106 Million
0.06% of portfolio
Janus Henderson Group PLC London, X0

6.62M
Shares

$105 Million
0.05% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.99B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wilbanks Smith & Thomas Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wilbanks Smith & Thomas Asset Management LLC with notifications on news.

Account